Experimental approaches using the ovarian cancer cell line SKOV-3 as a model system suggest various modes of action exerted by HNTMB based on the generation of ROS, caspase activation, Bcl-2 down-regulation, DNA degradation and G2/M phase cell cycle arrest. Here, BCL2 is linked to ovarian cancer.